Site search
2991 results for '' found
A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymph
A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymph
/
A Phase 3, Open-Label, Randomized Study of Sonrotoclax [BGB-11417] plus Zanubrutinib [BGB-3111] Compared with Venetoclax plus Acalabrutinib in Patients with Previously Untreated Chronic Lymphocyt
A Phase 3, Open-Label, Randomized Study of Sonrotoclax [BGB-11417] plus Zanubrutinib [BGB-3111] Compared with Venetoclax plus Acalabrutinib in Patients with Previously Untreated Chronic Lymphocyt
/
Are you active in your community and interested in quality healthcare?
Call for Applications for Membership of Bayside Health Community Advisory Committee
/news/are-you-active-in-your-community-and-interested-in-quality-healthcare
Co-Designed_Disability_Awareness_Training_Presentation.pdf
SPEAK_Disability_Data_Systems_Report.pdf
SPEAK_Disability_Education_Report.pdf
SPEAK_Summary_Report_2025.pdf
SPEAK_DLO_Rapid_Response_Service.pdf
Post_Concussion_Symptom_Checklist.pdf
https://app.prompt.org.au/download/259670?code=02b291b8-d09a-49b1-96fe-3d94b37f6293